Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nika Kianfar, MD"'
Autor:
Azin Dehghanimahmoudabadi, MD, Nika Kianfar, MD, MPH, Marwa Akhdar, MD, Shayan Dasdar, MD, MPH, Kamran Balighi, MD, Hamidreza Mahmoudi, MD, Maryam Daneshpazhooh, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 8, Iss 3, p e038 (2022)
Background: . Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. Objectives: . To report pregnancy outcomes of patients with pemphigus who were treated with R
Externí odkaz:
https://doaj.org/article/f4ffc1892393468ba169ead006d75ac0
Autor:
Nika Kianfar, MD-MPH, Shayan Dasdar, MD-MPH, Hamidreza Mahmoudi, MD, Maryam Daneshpazhooh, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 8, Iss 3, p e056 (2022)
Pemphigus vulgaris is a chronic autoimmune mucocutaneous blistering disorder. Apart from the disease itself, other aspects of patients’ life, including psychological, social, and financial, can be affected. Women are particularly more disposed to t
Externí odkaz:
https://doaj.org/article/d504de88561b46ac8d23891424360321
Autor:
Atefeh Behkar, MD, MPH, Gholamreza Garmaroudi, MD, MPH, PhD, Maryam Nasimi, MD, Msc, Shakiba Yousefi, MD, Hasan Khosravi, MD, Nika Kianfar, MD, Dedee F. Murrell, MD, Maryam Daneshpazhooh, MD
Publikováno v:
International Journal of Women's Dermatology, Vol 8, Iss 1, p e004 (2022)
Background:. In autoimmune bullous diseases (AIBDs), autoantibodies loosen molecular adhesions in the skin and/or mucosa and lead to blisters and erosions. Immunosuppressive drugs reduce mortality of the AIBD; therefore, patients will have to live lo
Externí odkaz:
https://doaj.org/article/eb95166e7bd1448496ad7180354171ba